ACM
Altium Capital Management Portfolio holdings
AUM
$34.4M
This Quarter Return
+27.24%
1 Year Return
-2.5%
3 Year Return
+357.21%
5 Year Return
–
10 Year Return
–
AUM
$195M
AUM Growth
+$195M
(-26%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-54.62%
Top 10 Holdings %
Top 10 Hldgs %
44.8%
Holding
156
New
23
Increased
14
Reduced
15
Closed
62
Top Buys
| 1 |
Astria Therapeutics
ATXS
|
$13.6M |
| 2 |
Replimune Group
REPL
|
$4.35M |
| 3 |
Tandem Diabetes Care
TNDM
|
$4.05M |
| 4 |
Amylyx Pharmaceuticals
AMLX
|
$3.88M |
| 5 |
Outlook Therapeutics
OTLK
|
$3.59M |
Top Sells
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$8.27M |
| 2 |
Insmed
INSM
|
$5.77M |
| 3 |
MBTC
Nocturne Acquisition Corporation Ordinary Shares
MBTC
|
$5.17M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$4.94M |
| 5 |
CBAY
Cymabay Therapeutics
CBAY
|
$4.55M |
Sector Composition
| 1 | Healthcare | 89.27% |
| 2 | Financials | 5.84% |
| 3 | Communication Services | 0.42% |
| 4 | Industrials | 0.37% |
| 5 | Materials | 0.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Palisade Bio
PALI
$6.04M
| – | – |
-5,643,007
| Closed | -$559K |
|
152
Procept Biorobotics
PRCT
$2.11B
| – | – |
-81,000
| Closed | -$3.36M |
|
153
QuidelOrtho
QDEL
$1.87B
| – | – |
-50,000
| Closed | -$3.57M |
|
154
uniQure
QURE
$954M
| – | – |
-105,000
| Closed | -$1.97M |
|
155
Relmada Therapeutics
RLMD
$48.8M
| – | – |
-8,500
| Closed | -$315K |
|
156
Avidity Biosciences
RNA
$6.12B
| – | – |
-150,000
| Closed | -$2.45M |
|